Federica Ramani

Federica Ramani

Auto-generated profile, based on publicly available information

Federica Ramani

Cardiovascular Department, ‘Ospedali Riuniti’ and University of Trieste , Trieste

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2019 in JACC
Verified
Journal Article
Closed access
MGMarta Gigli
Marta Gigli
MMMarco Merlo
Marco Merlo
SGSharon L. Graw
Sharon L. Graw
GBGiulia Barbati
Giulia Barbati
TRTeisha J. Rowland
Teisha J. Rowland
LMLuisa Mestroni
Luisa Mestroni

5 January 2015 in Journal of the American Heart Association
Verified
Journal Article
Open access
MMMarco Merlo
Marco Merlo
DSDavide Stolfo
Davide Stolfo
MAMarco Anzini
Marco Anzini
FNFrancesco Negri
Francesco Negri
BPBruno Pinamonti
Bruno Pinamonti
GSGianfranco Sinagra
Gianfranco Sinagra
Background: An important number of patients with idiopathic dilated cardiomyopathy have dramatically improved left ventricular function with optimal treatment; however, little is known about the evolution and long‐term outcome of this subgroup, which shows apparent healing. This study assesses whether real healing actually exists in dilated cardiomyopathy . Methods and Results: Persistent apparent healing was evaluated among 408 patients with dilated cardiomyopathy receiving tailored medical treatment and followed over the very long‐term. Persistent apparent healing was defined as left ventricular ejection fraction ≥50% and indexed left ventricular end‐diastolic diameter ≤33 mm/m 2 at both mid‐term (19±4 months) and long‐term (103±9 months) follow‐up. At mid‐term, 63 of 408 patients (15%) were apparently healed; 38 (60%; 9% of the whole population) showed persistent apparent healing at long‐term evaluation. No predictors of persistent apparent healing were found. Patients with persistent apparent healing showed better heart transplant–free survival at very long‐term follow‐up (95% versus 71%; P =0.014) compared with nonpersistently normalized patients. Nevertheless, in the very long term, 37% of this subgroup experienced deterioration of left ventricular systolic function, and 5% died or had heart transplantation. Conclusions: Persistent long‐term apparent healing was evident in a remarkable proportion of dilated cardiomyopathy patients receiving optimal medical treatment and was associated with stable normalization of main clinical and laboratory features. This condition can be characterized by a decline of left ventricular function over the very long term, highlighting the relevance of serial and individualized follow‐up in all patients with dilated cardiomyopathy , especially considering the absence of predictors for long‐term apparent healing.

1 September 2016 in JACC: Cardiovascular Imaging
Verified
Journal Article
Closed access
MMMarco Merlo
Marco Merlo
MGMarco Gobbo
Marco Gobbo
DSDavide Stolfo
Davide Stolfo
PLPasquale Losurdo
Pasquale Losurdo
FRFederica Ramani
Federica Ramani
GSGianfranco Sinagra
Gianfranco Sinagra

17 April 2017 in Heart
Verified
Journal Article
Closed access
PDF file
MFMatteo Dal Ferro
Matteo Dal Ferro
DSDavide Stolfo
Davide Stolfo
AAAlessandro Altinier
Alessandro Altinier
MGMarta Gigli
Marta Gigli
MPMartina Perrieri
Martina Perrieri
GSGianfranco Sinagra
Gianfranco Sinagra
Objective: To explore the genetic landscape of a well selected dilated cardiomyopathy (DCM) cohort, assessing the possible relation between different genotypes and left ventricular reverse remodelling (LVRR). Methods: A cohort of 152 patients with DCM from the Heart Muscle Disease Registry of Trieste has been studied by next-generation sequencing (NGS). Patients were grouped into different ‘gene-clusters’ with functionally homogeneous genetic backgrounds. LVRR was defined by left ventricular ejection fraction normalisation or increase ≥10% associated with normalisation in indexed left ventricular end-diastolic diameter or relative decrease ≥10% at 24 months follow-up. Results: A pathogenic disease-related gene variant was identified in 57% of patients: 28 (18%) TTN; 7 (5%) LMNA; 16 (11%) structural cytoskeleton Z-disk genes; 9 (6%) desmosomal genes; 18 (12%) motor sarcomeric genes and 9 (6%) other genes. Baseline clinical features were similar throughout the different genotypes. A significant relationship was found between gene cluster subgroups and LVRR, with a lower rate of LVRR in structural cytoskeleton Z-disk gene mutation carriers (1/16 patients, 6%, p<0.05 vs the other subgroups). Of note, structural cytoskeleton Z-disk gene rare variants were independently and inversely associated with LVRR when adjusted for clinical predictors of LVRR (OR 0.065; 95% CI 0.008 to 0.535, p=0.011). Conclusions: NGS confirmed a high genetic diagnostic yield in DCM. A specific ‘gene-clusters’ classification based on functional similarities in different genes might be helpful in the clinical management of genetically determined DCM. In this study, structural cytoskeleton Z-disk gene rare variants were independently associated with a lower rate of LVRR at follow-up.

3 October 2013 in Clinical and Translational Science
Verified
Journal Article
Closed access
PDF file
MMMarco Merlo
Marco Merlo
GSGianfranco Sinagra
Gianfranco Sinagra
ECElisa Carniel
Elisa Carniel
DSDobromir Slavov
Dobromir Slavov
XZXiao Zhu
Xiao Zhu
MTMatthew R. G. Taylor
Matthew R. G. Taylor

1 January 2020 in Canadian Journal of Cardiology
Verified
Journal Article
Closed access
ACAntonio Cannata
Antonio Cannata
EFEnrico Fabris
Enrico Fabris
MMMarco Merlo
Marco Merlo
JAJessica Artico
Jessica Artico
PGPiero Gentile
Piero Gentile
GSGianfranco Sinagra
Gianfranco Sinagra